🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Healthcare Services Group, Inc. HCSG R2K

Healthcare · Medical Care Facilities · United States
https://www.hcsgcorp.com

Healthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. The company operates in two segments, Environmental Services and Dietary. Its Environmental Services segment engages in cleaning, disinfecting, and sanitizing of resident rooms and common areas of the customers' facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing, and other assorted linen items utilized at the customers' facilities. The Dietary segment is involved in the management of the customers' dietary departments, which focus on food purchasing, meal preparation, and professional dietitian services, such as the development of menus that meet the dietary needs of residents; and the provision of on-site management and clinical consulting services. It serves long-term and post-acute care facilities, hospitals, and the healthcare industry through referrals and solicitation of target facilities. The company was incorporated in 1976 and is headquartered in Bensalem, Pennsylvania.

READ MORE ›
$20.60
+46.10% 1Y

Market & Price

Market Cap
$1.41B
Current Price
$20.60
High / Low (52W)
$23.06 / $12.69
Beta
0.85

Valuation

Stock P/E
21.68
Industry PE
23.65
Forward P/E
17.82
PEG Ratio
1.36
Book Value
$7.50
Price to Book
2.75
P/S
0.76
EV/EBITDA
18.39
Dividend Yield
-

Profitability & Returns

ROCE
11.13%
ROE
13.21%
ROA
4.53%
Profit Margin
3.67%
Op Margin
7.31%
EPS (Latest Qtr)
$0.37
EPS (TTM)
$0.95

Balance Sheet & Liquidity

Debt/Equity
2.85
Quick Ratio
2.70
Current Ratio
3.11
Debt
$14.65M
Total Assets
$794.25M
Current Assets
$576.41M
Working Capital
$406.04M

Ownership

Promoter Holding
1.40%
Chg in Prom Hold
0.02%
FII / Inst Holding
114.98%
Chg in FII Hold
-0.01%

Financial Snapshot

Enterprise Value
$1.25B
Total Revenue (TTM)
$1.85B
EBITDA
$67.98M
Free Cash Flow
$94.42M
Operating Cash Flow
$161.20M
Shares Outstanding
68.65M
Gross Margin
13.35%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
2.82%
Profit 5Y
19.92%
Revenue (YoY)
3.40%
Earnings (YoY)
60.90%

PROS

  • Profit CAGR of 19.9% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 HCSG Healthcare Services Group, Inc. R2K 20.60 21.68 $1.41B - 11.13% 13.21% 2.82% 19.92%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
Ad space

Quarterly Results

Figures in USD.

Metric Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ------------500.56M501.59M505.50M494.95M476.11M462.10M455.61M446.96M449.15M452.03M435.95M407.75M398.17M415.59M426.81M424.86M414.49M417.23M418.93M411.39M423.43M426.29M428.15M447.66M458.49M464.34M466.68M462.77M
Cost of Revenue -----------------------------------379.69M455.53M367.93M394.61M386.93M
Gross Profit -----------------------------------67.97M2.96M96.41M72.07M75.83M
Operating Expenses -----------------------------------46.43M44.51M46.82M45.83M43.57M
Operating Income -----------------------------------21.54M-41.56M49.58M26.24M32.27M
EBITDA -----------------------------------28.17M-36.47M61.73M32.80M38.71M
Interest Expense -----------------------------------395.00K418.00K393.00K374.00K365.00K
Pretax Income -----------------------------------23.89M-41.89M57.31M28.55M34.54M
Tax Provision -----------------------------------6.67M-9.52M14.36M-2.69M8.48M
Net Income 15.52M16.29M17.09M9.13M18.63M18.76M19.71M20.30M22.02M22.55M23.47M20.19M72.00K25.81M26.09M31.55M9.16M18.19M18.34M18.89M20.19M23.10M27.64M24.65M9.56M9.54M11.33M6.82M322.00K11.67M8.25M-5.05M15.31M-1.79M14.03M17.23M-32.37M42.95M31.24M26.06M
Diluted EPS 0.220.230.240.130.260.260.270.280.300.300.310.270.000.350.350.420.120.240.250.250.270.310.370.330.130.130.150.090.000.160.11-0.070.21-0.020.190.23-0.440.590.440.37

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue ---------1.86B2.00B1.84B1.76B-1.69B1.67B1.72B1.84B
Cost of Revenue --------------1.50B1.46B1.49B1.60B
Gross Profit --------------193.31M214.75M228.09M239.41M
Operating Expenses --------------149.52M166.77M174.82M183.60M
Operating Income --------------43.79M47.97M53.27M55.80M
EBITDA --------------62.86M75.26M73.96M86.22M
Interest Expense --------------2.99M7.86M6.44M1.58M
Pretax Income --------------44.55M53.06M52.94M67.87M
Tax Provision --------------10.31M14.67M13.47M8.81M
Net Income 26.61M30.34M34.44M38.16M44.21M47.13M21.85M58.02M77.40M88.23M83.52M64.58M98.68M-34.24M38.39M39.47M59.06M
Diluted EPS 0.400.460.510.560.650.670.310.801.051.191.120.871.32-0.470.520.530.81

Compounded Sales Growth

5 Years:2.82%
1 Year:3.40%

Compounded Profit Growth

5 Years:19.92%
1 Year:60.90%

Stock Price Performance

1 Year:+46.10%
6 Months:+9.23%
3 Months:-5.37%
1 Month:-3.42%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --265.89M277.93M289.69M331.18M425.34M469.58M480.95M528.45M676.00M692.60M722.59M785.03M-720.84M790.65M802.77M794.25M
Current Assets ---------------508.63M571.70M556.65M576.41M
Cash & Equivalents 92.46M37.50M31.30M39.69M38.64M68.95M64.16M75.28M33.19M23.85M9.56M26.02M27.33M--26.28M54.33M56.78M125.19M
Inventory ---------------21.16M18.48M16.75M16.80M
Receivables ---------------336.78M344.86M330.91M281.30M
Total Liabilities ---------------302.56M334.04M302.85M284.04M
Current Liabilities --34.72M40.53M45.39M67.66M99.10M117.96M96.06M100.87M184.17M163.39M148.65M162.26M-189.01M216.93M192.55M170.38M
Long Term Debt -------------------
Total Debt ---------------33.10M36.23M8.03M9.66M
Total Equity 194.72M201.68M208.77M213.08M217.73M229.57M285.14M275.83M296.46M338.84M399.95M440.78M460.31M470.28M-418.28M456.62M499.93M510.21M
Shares Outstanding ---------------76.16M76.33M76.53M76.82M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 16.66M38.31M37.75M32.95M60.38M32.16M57.73M63.36M41.40M7.63M80.03M93.58M217.21M--8.17M43.50M30.80M144.97M
Investing Cash Flow -49.86M-10.23M3.08M4.51M5.69M605.00K-6.46M-62.31M-6.45M-14.97M-9.59M-16.46M-36.84M-2.58M-3.29M6.05M-11.00M
Financing Cash Flow -21.76M-34.27M-32.44M-38.52M-35.75M-37.56M-40.15M-43.14M-44.28M-6.96M-53.98M-75.82M-68.37M--38.93M-12.15M-31.05M-63.33M
Capital Expenditure -1.58M-2.15M-4.17M-5.54M-3.48M-3.76M-5.79M-5.00M-5.44M-5.40M-4.94M-4.37M-4.34M--5.21M-5.41M-6.34M-5.82M
Free Cash Flow 15.09M36.15M33.57M27.40M56.89M28.40M51.94M58.36M35.96M2.23M75.09M89.21M212.87M--13.38M38.09M24.47M139.15M
Net Change in Cash ---------------44.52M28.05M5.80M70.64M
Share Buybacks 4.65M----------0021.54M011.28M5.02M61.59M

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % --------------11.4%12.8%13.3%13.0%
Operating Margin % --------------2.6%2.9%3.1%3.0%
Net Margin % ---------4.7%4.2%3.5%5.6%-2.0%2.3%2.3%3.2%
ROE % 13.2%14.5%16.2%17.5%19.3%16.5%7.9%19.6%22.8%22.1%18.9%14.0%21.0%-8.2%8.4%7.9%11.6%
ROCE % --------------8.2%8.4%8.7%8.9%

Shareholding Pattern

Insiders
1.40%
Institutions
114.98%
Public Float
116.61%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 16.69% 11.46M $236.05M
2 Vanguard Portfolio Management LLC 7.06% 4.85M $99.83M
3 Vanguard Capital Management LLC 4.54% 3.12M $64.26M
4 State Street Corporation 4.11% 2.82M $58.07M
5 Mackenzie Financial Corporation 3.89% 2.67M $55.05M
6 American Century Companies Inc 3.65% 2.51M $51.67M
7 Dimensional Fund Advisors LP 3.50% 2.40M $49.45M
8 Ameriprise Financial, Inc. 3.15% 2.17M $44.61M
9 Royce & Associates LP 3.12% 2.14M $44.15M
10 Geode Capital Management, LLC 2.98% 2.04M $42.12M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for HCSG

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks